Cellcolabs raised $8.7 million from private investors in Sweden.
14 February 2024
14 February 2024
Total investments received (USD): 32.09m
Round value (USD): 8.7m
Company: Cellcolabs
Industry:
Biotech
Health services
Related deals
Rarity Bioscience in a a €6.5 million funding round led by Navigare Ventures, joined by existing shareholders Novalis Biotech and UU Invest
Investments
09 June 2024
Symcel raised SEK 86 million with Lareim AB and Flerie Invest AB.
Investments
09 March 2024
Xinnate to raise an additional SEK 100 million
Investments
29 January 2024
Pixelgen in a $7.3 million series A round co-led by Industrifonden and Navigare Ventures.
Investments
05 October 2023
Netherlands
Austria
Germany
Switzerland
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
France
Ireland
Italy
Portugal
Spain
United Kingdom